Renergen has developed the ground-breaking Cryo-VaccTM

Explore Renergen

Cryo-Vacc TM is a wholly owned subsidiary of Renergen Limited.

Renergen has developed the ground-breaking Cryo-VaccTM, (listed on the JSE and ASX) which enables the safe transportation of vaccines at extremely low temperatures, without the need for (an external power source) electrical power.

Learn more about Renergen